ArisGlobal Among Cloud Top 500

ArisGlobal Strengths, Domain Expertise, and Key Differentiators

ArisGlobal is a visionary technology company that’s transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market.

The ArisGlobal LifeSphere cognitive technology platform integrates machine-learning capabilities to automate the core functions of the product lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, their cognitive platform delivers actionable insights, boosts efficiency, ensures compliance, and lowers total cost of ownership through multi-tenancy.

Risk Management, a key solution within LifeSphere Safety, the multi-tenant cloud Pharmacovigilance and Safety platform suite, delivers significant improvements including:

- Smarter signal detection algorithms to reduce noise-to-signal ratio.

- End-to-end workflow to streamline signal detection, signal management and risk management planning activities and to capture the full range of decisions from identification to actions.

- A user-friendly graphical interface supported by advanced analytics, visualization and computational engine.

- Comprehensive reporting capabilities to support regulatory and business requirements including Compliance, Inspections, PBRER and KPI.

- Ability to capture and analyze social media sentiment through natural language processes for comprehensive analysis LifeSphere Safety – Risk Management is aligned with ArisGlobal’s overall LifeSphere® vision that is based on providing multi-tenancy cloud deployment, an open and integrated architecture, solutions based on industry standard practices, and the delivery of advanced automation capabilities.

ArisGlobal Recent Developments

In June 2020, ArisGlobal launched LifeSphere Regulatory, an all-new cloud platform that addresses the full end-to-end regulatory management process in a simple, unified suite. The new LifeSphere Regulatory platform includes LifeSphere RIMS, a complete solution for managing all core regulatory processes, and LifeSphere Publishing, a submissions management system that enables life science organizations to easily compile, publish, and validate regulatory submissions with full support for all major global eCTD requirements. LifeSphere Regulatory is also integrated with LifeSphere EasyDocs, a modern cloud document management platform that enables a single source of truth for data and documents across R&D business processes.

In April 2020, ArisGlobal released its LifeSphere CTMS10, a modern, end-to-end solution that makes the entire clinical trial management process easier and more transparent for companies of all sizes. Offering global oversight and visibility, LifeSphere CTMS10 enables life sciences organizations to plan, track, and control all trial set-up, conduct, and closeout activities using a simple, intuitive interface designed for all levels of experience. Unlike other CTMS applications, LifeSphere CTMS10 also includes payments and monitoring modules out-of-the-box, ensuring fast, accurate disbursements to research sites and maximizing CRA effectiveness in the field.

In March 2019, ArisGlobal launched LifeSphere Publishing, a complete, pre-validated submissions management system that enables life science organizations to easily plan, compile, publish, and validate regulatory submissions with full support for all major global eCTD requirements. LifeSphere Publishing can be used as a standalone application or as an integral part of ArisGlobal’s LifeSphere Regulatory end-to-end cloud platform for regulatory affairs.

In March 2019, ArisGlobal launched LifeSphere EasyDocs, an advanced cloud platform that streamlines enterprise document management across the product development lifecycle. Seamlessly woven into ArisGlobal’s LifeSphere ecosystem, which includes the LifeSphere® Clinical, Regulatory, Safety, and Medical Affairs platforms, life sciences organizations will now have a highly configurable, scalable solution that gives users a unified view of content and data across all domains. LifeSphere EasyDocs significantly improves user productivity and operational efficiency and delivers the critical ‘single source of truth’ for assured compliance across the end-to-end development lifecycle.

As part of the LifeSphere cognitive platform, LifeSphere Publishing works seamlessly with LifeSphere® EasyDocs, also announced today, to provide a fully unified content and submission management solution. Built on open SOA architecture, the solution offers configurable APIs to enable easy integration with other document management systems such as Documentum, D2, SharePoint, and more.

In June 2017, ArisGlobal Introduced LifeSphere Safety – Risk Management, a multi-tenant, cloud-based solution that offers a comprehensive set of data analytics, workflow and reporting tools for end-to-end signal detection and risk management. This newest ArisGlobal offering gives today’s life sciences company the leading technology necessary, such as cognitive computing capabilities and multi-tenant cloud deployment, to realize significant efficiencies and effectiveness across their benefit-risk processes.

ArisGlobal Mergers and Acquisitions (M&A) Activities

In June 2019, Nordic Capital Fund IX announced an agreement to acquire US-headquartered ArisGlobal, a global provider of innovative SaaS software solutions, which are transforming the way the most successful life sciences companies handle drug safety, clinical development, regulatory compliance, and medical affairs. Drawing on its deep understanding of both the healthcare and technology sectors, Nordic Capital will support ArisGlobal’s continued development. The founders of ArisGlobal remained as minority shareholders.

ArisGlobal Customers in ARTW Customer Database

Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying ArisGlobal applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of ArisGlobal and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified ArisGlobal LifeSphere Platform customers.

ArisGlobal Key Enterprise and Cloud Applications

ArisGlobal LifeSphere Platform

ArisGlobal Revenues, $M:

ArisGlobal Revenue Breakdown By Type, $M:

ArisGlobal Enterprise Applications Revenues By Functional Markets, $M:

ArisGlobal Enterprise Applications Revenues By Verticals, $M:

ArisGlobal Revenues By Region, $M

ArisGlobal Direct vs Indirect sales

ArisGlobal Customers - Breakdown by Geo, Size, Vertical and Product

List of Verified ArisGlobal Customers

No. of ArisGlobal Customers: 300

No. of ArisGlobal Enterprise Applications Customers: 300

No. of ArisGlobal Cloud Customers: x

No. of ArisGlobal Cloud Subscribers: x

More than 300 life science companies rely on ArisGlobal to facilitate regulatory compliance, manage risk and improve operational efficiency.

Among ArisGlobal customers are SPIMACO, Seikagaku Corporation, Linde Healthcare, Merz Pharmaceuticals, Dohmen Life Science Services (DLSS), AstraZeneca, SIRO Clinpharm, China FDA Center of Drug Evaluation, and others.

ArisGlobal Market Opportunities, M&A and Geo Expansions

In May 2020, Nordic Capital, a private equity investor with a resolute commitment to creating stronger, sustainable businesses, announced a further investment in ArisGlobal, by acquiring an additional shareholding from the founding Abbhi family. The transaction followed Nordic Capital’s initial investment in ArisGlobal, a provider of innovative software-as-a-service (SaaS) solutions for the life sciences industry in 2019 and subsequent years of significant growth for the Miami-based company. Drawing on its deep understanding of both the healthcare and technology sectors, Nordic Capital will continue to support ArisGlobal’s growth, with further investment into research and development, cognitive computing, global delivery, and commercial operations.

In October 2018, ArisGlobal launched LifeSphere MultiVigilance (LSMV) the next-generation platform for individual case safety report (ICSR) intake powered by LifeSphere Nava – ArisGlobal’s cognitive computing engine.

LifeSphere MultiVigilance is developed on a completely new, cutting-edge technology architecture designed for the cloud with the latest robotic automation and cognitive computing technologies including natural language processing (NLP) and machine learning to transform all pharmacovigilance (PV) activities.

LifeSphere MultiVigilance is unified platform fully integrated with product quality complaints and medical information management, delivering a new dimension on compliance with seamless exchange of safety cases between these critical functions.

ArisGlobal has been partnering with leading pharmaceutical companies and regulatory agencies to develop the new platform. Together, ArisGlobal and its strategic partners focused on identifying business critical problems within safety case processing, and then identified innovative ways to solve these problems. Each of the PV platform’s automation functions were extensively tested during the development process by ArisGlobal’s PV and IT experts, with additional PV expertise provided by its partners.

ArisGlobal Risks and Challenges

Over the past few years, ArisGlobal made changes in their leadership by appointing a new Chief Executive Officer, Chief Strategy Officer and Chief Commercial Officer. This changes could lead to different company strategy and goals.

ArisGlobal Ecosystem, Partners, Resellers and SI

In December 2020, EVERSANA, a provider of next-generation commercial services to the life sciences industry, and ArisGlobal, a provider of life sciences software that automates drug development functions, announced a strategic partnership to digitally transform end-to-end pharmacovigilance services, leading to safer, more effective healthcare for patients worldwide. Under the terms of the partnership, EVERSANA will utilize ArisGlobal’s end-to-end LifeSphere Safety Platform for clinical and commercial product safety management, including intelligent automation and machine-learning-enhanced adverse event case processing. The EVERSANA and ArisGlobal strategy partnership will help respective clients make critical decisions around product life cycle management, including therapeutic area or geographic expansion, predictive safety for targeted population, off-label use and personalized safety in the era of gene and cell therapy.

Direct Sales in USA, UK, France, Germany, Ireland, Italy, Belgium, India, and Japan.

In Japan ArisGlobal sells through channel partner CTC Laboratory Systems.

Furthermore it partners with vendors such as EMC, IBM, Medidata and SAP to shore up integration between its Cloud-based offerings and other backend systems.

ArisGlobal Cloud Infrastructure Insights

Subscribe to read more about:

• ArisGlobal Public Cloud and Infrastructure (IaaS)
• ArisGlobal Platform (PaaS)
• ArisGlobal Application Delivery
• ArisGlobal Private Cloud and Data Centers

Research Methodology

Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.

Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).

For additional information on our methodologies, here's the link:

Copyright © 2022, APPS RUN THE WORLD